ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 128

Treatment Response in Polyarticular Juvenile Idiopathic Arthritis is Associated With Transcriptional Changes and Chromatin Reorganization in CD4+ T cells

Evan Tarbell1, Kaiyu Jiang2, Yanmin Chen2, Tao Liu3 and James Jarvis4, 1Biochemistry, University at Buffalo, Buffalo, NY, 2Pediatrics, University at Buffalo, Buffalo, NY, 3Department of Biochemistry, University at Buffalo, Buffalo, NY, 4Pediatrics, SUNY Buffalo School of Medicine, Buffalo, NY

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: CD T cells, epigenetics and juvenile arthritis, Gene Expression

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Thursday, May 18, 2017

Title: Genetics and Pathogenesis Poster Session

Session Type: Abstract Submissions

Session Time: 5:30PM-7:00PM

Background/Purpose: The polyarticular form of JIA is associated with well-documented transcriptional abnormalities in peripheral blood cells. The abnormalities can be observed in neutrophils, peripheral blood mononuclear cells, and whole blood gene expression profiles. The mechanisms underlying these abnormalities are incompletely understood. Furthermore we have little understanding of how commonly used therapies impact the observed transcriptional aberrations.

Methods: We isolated RNA from CD4+ T cells of children with 3 distinct phenotypes: children with active, treated polyarticular JIA (ADT, n=12), children on medication who fit criteria for clinical remission by the Wallace criteria (CRM, n=10), and 10 healthy children, a control group. RNA sequencing was performed using the Illumina HiSeq 2500 platform. In addition, we used the assay for transposase-accessible chromatin-sequencing (ATACseq) to survey open chromatin in a subset of these same patients (6 HC, and 5 ADT and CRM).

Results: Each of the 3 phenotypes was associated with its own its own chromatin accessibility signature as identified by ATACseq and its own transcriptional signature. We identified 16,039 accessible sites that were unique to HC, 38,451 that were unique to ADT, and 58,289 sites that were unique to CRM. Further analyses of the open regions unique to the HC cells showed that these regions were highly enriched (compared to genome background) for CCCTC-binding factor (CTCF) binding sites. These CTCF binding sites were absent in JIA CD4+ T cells. This finding suggests that aberrant 3D chromatin architecture (which is regulated by CTCF) may be a primary driver of the transcriptional aberrations observed in JIA. In contrast, open regions that were unique to the ADT state were highly enriched for NFIC and STAT4 binding sites. Both NFIC and STAT4 are known regulators of T cell activation, and the STAT4 locus has been identified as a region of genetic risk in JIA. Analysis of the combined RNAseq and ATACseq using BETA software demonstrated that the differences in chromatin accessibility had high regulatory potential for the differentially expressed genes, providing strong evidence that the chromatin changes and gene expression changes are causally linked. The CRM state was not associated with normalization of either the chromatin or transcriptional signatures of CD4+ T cells in children with JIA.

Conclusion:

Conclusion – Treatment response in JIA is associated with significant re-organization of chromatin and is accompanied by significant changes in transcription that can be attributed to the chromatin re-organization. Patterns of chromatin accessibility suggest important roles for chromatin regulators (e.g., CTCF) and transcription factors (NFIC, STAT4) in JIA. The achievement of CRM does not result in a normalization of either the transcriptome or the epigenome of CD4+ T cells.


Disclosure: E. Tarbell, None; K. Jiang, None; Y. Chen, None; T. Liu, None; J. Jarvis, None.

To cite this abstract in AMA style:

Tarbell E, Jiang K, Chen Y, Liu T, Jarvis J. Treatment Response in Polyarticular Juvenile Idiopathic Arthritis is Associated With Transcriptional Changes and Chromatin Reorganization in CD4+ T cells [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/treatment-response-in-polyarticular-juvenile-idiopathic-arthritis-is-associated-with-transcriptional-changes-and-chromatin-reorganization-in-cd4-t-cells/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/treatment-response-in-polyarticular-juvenile-idiopathic-arthritis-is-associated-with-transcriptional-changes-and-chromatin-reorganization-in-cd4-t-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology